10 Reasons Adults Tracking ALT Are Quitting Milk Thistle for One 12mg Softgel

Twenty miles a week of running. No sugar since the first of August. Diet logged on the same Mead legal pad you use for everything. And the ALT column climbed 22, 24, 31, 38, 51, 78. That's not a discipline problem. Think of your liver like a small refinery: the processing units inside the cells slow down with age, and the fat piles up in the tank instead of getting burned.

Your liver cells have tiny engines inside that burn fatty acids. Milk thistle protects the outside of the cell. It doesn't touch the engine. When the engine slows, the fat keeps arriving and stacks up. That's your steatosis. The mechanism research published since 2020 is finally clear on this — and it's exactly the layer milk thistle was never built to touch. (The science calls these engines mitochondria.)

Swapping bottles won't restart the engine. Nutrivein TUDCA, Thorne NAC, vitamin E at 800 IU, Jarrow milk thistle — all act on protective layers above the failure point. Fish oil at four grams moves triglycerides; it doesn't restart the processing unit. The bottle changes. The engine stays off.

An ALT of 51 in a range of 7 to 56 sits at the 91st percentile. The lab doesn't bold the 91st percentile. It bolds the number when it's red. An ALT that drifts from 22 to 31 to 51 to 78 over five years is a monotonic line, not noise. A reference range tells you where the herd grazes. It does not tell you where you are heading.

Your liver cells have walls. Most antioxidants bounce off the outside. Astaxanthin is small enough and oily enough to sit inside the wall — including the wall around each engine. Once it's there, it helps the engine respond to its ignition signal again. One molecule. Two jobs at the same place milk thistle can't reach. (The science calls these cell-membrane spanning + FGF21 / PGC-1α restoration.)

A 2020 pilot study took twelve adults with biopsy-confirmed fatty-liver disease and gave them 12 mg of astaxanthin daily for twenty-four weeks. Their steatosis grade dropped on follow-up biopsy. So did the activity score. (Nie et al. in the Sayuti 2023 systematic review on PubMed if you want the data table.)

The trials that moved the biopsy used 12 milligrams a day. Most softgels on the shelf sell 4 to 6 mg — barely a third of what researchers studied. Onavya delivers the full 12 mg in one softgel, sourced from Haematococcus pluvialis microalga (the same source the studies used) and paired with oil so your body actually absorbs it. No filler. No 4 mg shortcut.

Your liver burns fat like a furnace. With age the ignition signal weakens, the burn slows, and the fat stacks up. Researchers found astaxanthin restores the ignition signal in lab work on liver cells that had shut it off. (Wu 2020 in the British Journal of Pharmacology — the FGF21 mitochondrial pathway, full citation if you want to look it up.)

This isn't a four-gram fish-oil regimen and it isn't a 500 mg morning TUDCA. You take one small softgel with your morning coffee and walk away. No fishy burps. No calf cramps. No vitamin-store aftertaste. No serious side effects have been reported at doses up to 20 mg a day in the published trials. The most common note is a faintly reddish tint in stool — a harmless trait of carotenoids (the same family that colors carrots orange).

Take it for ninety days — a third of the duration the longest published trial ran. Let your hepatologist read the next ALT, AST, and GGT. If the line in your spreadsheet hasn't started to bend — full refund, no questions, no fine print. The risk lives on our side, not on the next column of your spreadsheet.